Insider · CIK 0001216838
Samuel N Hazen
Files at HCA (HCA Healthcare, Inc.). First filing Feb 5, 2026, latest Feb 5, 2026.
In brief
Samuel N Hazen files SEC Form 4 as CEO and director at HCA (HCA Healthcare, Inc.). Since Feb 5, 2026, Samuel N Hazen has reported 0 open-market buys worth $0 and 1 open-market sell worth $21M, the latest filed on Feb 5, 2026.
A track record needs three past buys with six months of prices behind them; Samuel N Hazen has 0, so none is measured yet.
The newest scored trade: sold $21M of HCA on Feb 3, 2026, filed Feb 5, 2026, scored 85 (strong). In the last 12 months: 0 buys worth $0 and 1 sell worth $21M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCA: HCA Healthcare, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 85Strong | HCA Healthcare, Inc. | $21M 42,877 shares | -57% | +64% from low-3% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | 42,877 0.02% of outstanding | $21M | Feb 3, 2026 | none |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | HCA HCA Healthcare, Inc. | AGrant or award Common Stock | +54,934 | $0.00 | $0 | 86,165 | Feb 12, 2026 |
| Feb 10, 2026 | HCA HCA Healthcare, Inc. | FTax withholding Common Stock | -21,323 | $502.05 | $11M | 64,842 | Feb 12, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -14,716 | $502.95 | $7.4M | 60,437 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -5,002 | $502.15 | $2.5M | 55,435 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -7,395 | $500.69 | $3.7M | 48,040 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -6,189 | $500.02 | $3.1M | 41,851 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -5,162 | $498.80 | $2.6M | 36,689 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -4,293 | $498.12 | $2.1M | 32,396 | Feb 5, 2026 |
| Feb 3, 2026 | HCA HCA Healthcare, Inc. | SOpen-market sale Common Stock | -120 | $497.18 | $60k | 32,276 | Feb 5, 2026 |
| Feb 4, 2026 | HCA HCA Healthcare, Inc. | JOther Common Stock | -1,045 | $498.35 | $521k | 31,231 | Feb 5, 2026 |
| Feb 4, 2026 | HCA HCA Healthcare, Inc. | JOther Common Stockindirect: By HD Trust | +1,045 | $498.35 | $521k | 16,024 | Feb 5, 2026 |
| Jan 30, 2026 | HCA HCA Healthcare, Inc. | MOption exercise Common Stock | +84,360 | $81.96 | $6.9M | 116,636 | Feb 2, 2026 |
| Jan 30, 2026 | HCA HCA Healthcare, Inc. | FTax withholding Common Stock | -41,483 | $488.27 | $20M | 75,153 | Feb 2, 2026 |
| Jan 29, 2026 | HCA HCA Healthcare, Inc. | AGrant or award Stock Appreciation Rightderivative | +55,846 | $0.00 | $0 | 55,846 | Feb 2, 2026 |
| Jan 30, 2026 | HCA HCA Healthcare, Inc. | MOption exercise Stock Appreciation Rightderivative | -84,360 | $0.00 | $0 | 0 | Feb 2, 2026 |
| Nov 14, 2025 | HCA HCA Healthcare, Inc. | GGift Common Stock | -14,830 | $0.00 | $0 | 32,276 | Nov 18, 2025 |
| Oct 31, 2025 | HCA HCA Healthcare, Inc. | MOption exercise Common Stock | +58,050 | $69.58 | $4.0M | 75,279 | Nov 4, 2025 |
| Oct 31, 2025 | HCA HCA Healthcare, Inc. | FTax withholding Common Stock | -28,173 | $459.68 | $13M | 47,106 | Nov 4, 2025 |
| Oct 31, 2025 | HCA HCA Healthcare, Inc. | MOption exercise Stock Appreciation Rightderivative | -58,050 | $0.00 | $0 | 0 | Nov 4, 2025 |
| May 13, 2025 | HCA HCA Healthcare, Inc. | GGift Common Stockindirect: By 2022 GRAT | -90,076 | $0.00 | $0 | 0 | May 15, 2025 |
| May 13, 2025 | HCA HCA Healthcare, Inc. | GGift Common Stockindirect: By 2023 Trust | +90,076 | $0.00 | $0 | 93,088 | May 15, 2025 |
| Feb 13, 2025 | HCA HCA Healthcare, Inc. | AGrant or award Common Stock | +13,218 | $0.00 | $0 | 76,418 | Feb 18, 2025 |
| Feb 13, 2025 | HCA HCA Healthcare, Inc. | FTax withholding Common Stock | -4,742 | $321.92 | $1.5M | 71,676 | Feb 18, 2025 |
| Jan 28, 2025 | HCA HCA Healthcare, Inc. | AGrant or award Stock Appreciation Rightderivative | +74,620 | $0.00 | $0 | 74,620 | Jan 30, 2025 |
Questions about Samuel N Hazen
Answered from the filings on this page, as of the latest one.
Is Samuel N Hazen buying or selling?
In the last 12 months Samuel N Hazen reported 0 open-market buys worth $0 and 1 open-market sell worth $21M on SEC Form 4; the latest was sold $21M of HCA on Feb 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Samuel N Hazen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samuel N Hazen has 0.
Where does Samuel N Hazen file Form 4?
Samuel N Hazen has filed Form 4 at HCA (HCA Healthcare, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.